Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurology Clinic, PC
1601
mi
from 91732
Cordova, TN
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurology Clinic, PC
1601
mi
from 91732
Cordova, TN
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
NeuroStudies.net
1924
mi
from 91732
Decatur, GA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
NeuroStudies.net
1924
mi
from 91732
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
NoesisPharma Clinical Trials
343
mi
from 91732
Phoenix, AZ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
NoesisPharma Clinical Trials
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Oklahoma Clinical Research Center
mi
from 91732
Oklahoma City, OK
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Oklahoma Clinical Research Center
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Olive Branch Family Medical
1600
mi
from 91732
Olive Branch, MS
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Olive Branch Family Medical
1600
mi
from 91732
Olive Branch, MS
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Pacific Research Network
103
mi
from 91732
San Diego, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Pacific Research Network
103
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Premiere Research Institute at Palm Beach Neurology
2300
mi
from 91732
West Palm Beach, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Premiere Research Institute at Palm Beach Neurology
2300
mi
from 91732
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
QUEST Research Institute
1952
mi
from 91732
Farmington Hills, MI
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
QUEST Research Institute
1952
mi
from 91732
Farmington Hills, MI
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Research Center for Clinical Studies, Inc.
2462
mi
from 91732
Norwalk, CT
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Research Center for Clinical Studies, Inc.
2462
mi
from 91732
Norwalk, CT
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Research Foundation for Mental Hygiene, Inc.
2434
mi
from 91732
Orangeburg, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Research Foundation for Mental Hygiene, Inc.
2434
mi
from 91732
Orangeburg, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
RI Hospital
2562
mi
from 91732
Providence, RI
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
RI Hospital
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Ruan Neurology Clinic and Research Center
1423
mi
from 91732
Des Moines, IA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Ruan Neurology Clinic and Research Center
1423
mi
from 91732
Des Moines, IA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
San Francisco Clinical Research Center
355
mi
from 91732
San Francisco, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
San Francisco Clinical Research Center
355
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Schuster Medical Research Institute
25
mi
from 91732
Sherman Oaks, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Schuster Medical Research Institute
25
mi
from 91732
Sherman Oaks, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Senior Adults Specialty Research
1212
mi
from 91732
Austin, TX
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Senior Adults Specialty Research
1212
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Southern California Research, LLC
25
mi
from 91732
Fountain Valley, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Southern California Research, LLC
25
mi
from 91732
Fountain Valley, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
The Clinical Trial Center, LLC
2377
mi
from 91732
Jenkintown, PA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
The Clinical Trial Center, LLC
2377
mi
from 91732
Jenkintown, PA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Roskamp Institute
2145
mi
from 91732
Sarasota, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Roskamp Institute
2145
mi
from 91732
Sarasota, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
USF Health Byrd Alzheimer's Institute
2133
mi
from 91732
Tampa, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
USF Health Byrd Alzheimer's Institute
2133
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Wake Research Associates, LLC
2214
mi
from 91732
Raleigh, NC
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Wake Research Associates, LLC
2214
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Xenoscience, Inc / 21st Century Neurology
344
mi
from 91732
Phoenix, AZ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Xenoscience, Inc / 21st Century Neurology
344
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
CITrials, Inc.
14
mi
from 91732
Bellflower, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
CITrials, Inc.
14
mi
from 91732
Bellflower, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Synergy East
108
mi
from 91732
Lemon Grove, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Synergy East
108
mi
from 91732
Lemon Grove, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Compass Research, LLC - North Clinic
2142
mi
from 91732
The Villages, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Compass Research, LLC - North Clinic
2142
mi
from 91732
The Villages, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
PRA Health Sciences
569
mi
from 91732
Salt Lake City, UT
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
PRA Health Sciences
569
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Discipline of Psychiatry, University of Queensland
7197
mi
from 91732
Herston,
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Discipline of Psychiatry, University of Queensland
7197
mi
from 91732
Herston,
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Xenoscience, Inc / 21st Century Neurology
344
mi
from 91732
Phoenix, AZ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Xenoscience, Inc / 21st Century Neurology
344
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Feldman, Robert MD
38
mi
from 91732
Laguna Hills, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Feldman, Robert MD
38
mi
from 91732
Laguna Hills, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
University of Southern California
11
mi
from 91732
Los Angeles, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
University of Southern California
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Pacific Research Network
103
mi
from 91732
San Diego, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Pacific Research Network
103
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
San Francisco Clinical Research Center
355
mi
from 91732
San Francisco, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
San Francisco Clinical Research Center
355
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Yale University School of Medicine
2486
mi
from 91732
New Haven, CT
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Yale University School of Medicine
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
JEM Research, LLC
2307
mi
from 91732
Atlantis, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
JEM Research, LLC
2307
mi
from 91732
Atlantis, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Brain Matters Research
2308
mi
from 91732
Delray Beach, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Brain Matters Research
2308
mi
from 91732
Delray Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
CNS Healthcare, Inc
2130
mi
from 91732
Jacksonville, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
CNS Healthcare, Inc
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Compass Research, LLC: North Clinic
2149
mi
from 91732
Leesburg, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Compass Research, LLC: North Clinic
2149
mi
from 91732
Leesburg, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Miami Research Associates
2322
mi
from 91732
Miami, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Miami Research Associates
2322
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Compass Research LLC
2184
mi
from 91732
Orlando, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Compass Research LLC
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
iResearch Atlanta LLC
1924
mi
from 91732
Decatur, GA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
iResearch Atlanta LLC
1924
mi
from 91732
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Alexian Brothers Neurosciences Institute
1713
mi
from 91732
Elk Grove, IL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Alexian Brothers Neurosciences Institute
1713
mi
from 91732
Elk Grove, IL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
ActivMed Practices & Research
2570
mi
from 91732
Methuen, MA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
ActivMed Practices & Research
2570
mi
from 91732
Methuen, MA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Olive Branch Family Medical
1600
mi
from 91732
Olive Branch, MS
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Olive Branch Family Medical
1600
mi
from 91732
Olive Branch, MS
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Memory Enhancement Centers of America, Inc
2432
mi
from 91732
Eatontown, NJ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Memory Enhancement Centers of America, Inc
2432
mi
from 91732
Eatontown, NJ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
CRI Worldwide
2388
mi
from 91732
Marlton, NJ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
CRI Worldwide
2388
mi
from 91732
Marlton, NJ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Advanced Memory Research Institute of NJ PC
2423
mi
from 91732
Toms River, NJ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Advanced Memory Research Institute of NJ PC
2423
mi
from 91732
Toms River, NJ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurological Associates of Albany, P. C.
2438
mi
from 91732
Albany, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurological Associates of Albany, P. C.
2438
mi
from 91732
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
SPRI
2440
mi
from 91732
Brooklyn, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
SPRI
2440
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurobehavioral Clinical Research
2042
mi
from 91732
Canton, OH
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurobehavioral Clinical Research
2042
mi
from 91732
Canton, OH
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
The Clinical Trial Center, LLC
2377
mi
from 91732
Jenkintown, PA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
The Clinical Trial Center, LLC
2377
mi
from 91732
Jenkintown, PA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
FutureSearch Trials of Neurology
1210
mi
from 91732
Austin, TX
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
FutureSearch Trials of Neurology
1210
mi
from 91732
Austin, TX
Click here to add this to my saved trials